Literature DB >> 6542363

Radioimmunoassay for alpha-human and rat atrial natriuretic polypeptide.

K Nakao, A Sugawara, N Morii, M Sakamoto, M Suda, J Soneda, T Ban, M Kihara, Y Yamori, M Shimokura.   

Abstract

Using a synthetic common carboxy-terminal fragment of alpha-human atrial natriuretic polypeptide (alpha-hANP) and alpha-rat atrial natriuretic polypeptide (alpha-rANP), we have produced an antiserum for alpha-ANP(17-28) and established a radioimmunoassay (RIA) for alpha-ANP that recognizes alpha-hANP and alpha-rANP equally. High performance gel permeation chromatography coupled with the RIA revealed that alpha-hANP-like immunoreactivity (alpha-hANP-LI) in the human atrium consists of three major components, gamma-hANP, alpha-hANP and another. On the other hand, alpha-rANP-LI in the rat atrium comprised at least two components, 13K alpha-rANP-LI and 3K-5K alpha-rANP-LI, which were presumably gamma-rANP and beta-rANP, respectively. Thus, considerable amounts of gamma-hANP and gamma-rANP are present in human right auricles and rat atria, respectively. The RIA established in this study provides a useful tool to investigate the pathophysiological significance of alpha-ANP and related peptides in cardiovascular disorders and shows that gamma-ANP is not only a precursor of alpha-ANP but acts as an important hormone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542363     DOI: 10.1016/0006-291x(84)91030-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Hypoxia regulates the natriuretic peptide system.

Authors:  Olli Arjamaa; Mikko Nikinmaa
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-07

2.  Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.

Authors:  A Sugawara; K Nakao; N Morii; T Yamada; H Itoh; S Shiono; Y Saito; M Mukoyama; H Arai; K Nishimura
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

Review 3.  The biochemistry and molecular biology of atrial natriuretic factor.

Authors:  T G Flynn; P L Davies
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

4.  Immuohistochemical demonstration of alpha-atrial natriretic plypeptide-containing neurons in the rat brain.

Authors:  M Kawata; S Ueda; K Nakao; N Morii; Y Kiso; H Imura; Y Sano
Journal:  Histochemistry       Date:  1985

5.  The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects.

Authors:  K Nakao; A Sugawara; N Morii; M Sakamoto; T Yamada; H Itoh; S Shiono; Y Saito; K Nishimura; T Ban
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

7.  Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".

Authors:  S Suga; K Nakao; H Itoh; Y Komatsu; Y Ogawa; N Hama; H Imura
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides.

Authors:  N Tamura; Y Ogawa; H Itoh; H Arai; S Suga; O Nakagawa; Y Komatsu; I Kishimoto; K Takaya; T Yoshimasa
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Atrial natriuretic peptide (ANP): a study of ANP and its mRNA in cardiocytes, and of plasma ANP levels in non-obese diabetic mice.

Authors:  H Mifune; S Suzuki; J Honda; Y Kobayashi; Y Noda; Y Hayashi; K Mochizuki
Journal:  Cell Tissue Res       Date:  1992-02       Impact factor: 5.249

10.  Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; H Tanaka; K Kikuta; H Sumida; H Kato; M Jougasaki; K Nakao
Journal:  Br Heart J       Date:  1994-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.